Literature DB >> 10022162

Reoperation for Hirschsprung's disease.

T R Weber1, R S Fortuna, M L Silen, P A Dillon.   

Abstract

BACKGROUND/
PURPOSE: Reoperation for Hirschsprung's disease traditionally has been used for patients with anastomotic leaks or stricture or with severe constipation from retained aganglionic segment or neuronal dysplasia, but there is little information regarding its use for other complications and the long-term outcome in these patients.
METHODS: In a 23-year period, 107 infants and children underwent Soave (68 patients) or Duhamel (39 patients) pull-through procedures. The age at operation was newborn to 6 years (mean, 10 months). Eighty percent had aganglionosis limited to the rectosigmoid colon. Follow-up was by office visit or telephone (mean, 8.5 years).
RESULTS: Twenty-three of the 68 patients with Soave pull-through (34%) underwent reoperation for intractable enterocolitis (10 patients, all 10 cured); anastomotic stenosis (four patients, three cured, one continued diversion); anastomotic leak (four patients, four cured); retained aganglionic segment (three patients, three cured); one necrosis of pull-through converted to Duhamel and cured; and one rectal prolapse that was diverted. Fifteen of the 39 patients with Duhamel procedure (38%) underwent reoperation for severe constipation (seven patients, six cured, one diverted); persistent rectal septum (four patients, 4 cured); and intractable enterocolitis (four patients, three cured, one diverted). Overall, 21 of 23 patients (91%) with reoperation after Soave procedures were cured, whereas 13 of 15 patients (87%) who underwent reoperation after Duhamel procedure were cured, and four patients remain diverted.
CONCLUSIONS: These data show that aggressive reoperation can result in a high cure rate in Hirschsprung's disease. Although there is no significant difference in the rate of reoperation after Duhamel and Soave procedures, the patients with Soave pull-through required more complex reoperations, with several requiring more than one procedure. An aggressive approach to reoperation in patients with Hirschsprung's disease clearly is justified.

Entities:  

Mesh:

Year:  1999        PMID: 10022162     DOI: 10.1016/s0022-3468(99)90247-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  11 in total

1.  Hirschsprung's Disease.

Authors:  William M. Belknap
Journal:  Curr Treat Options Gastroenterol       Date:  2003-06

Review 2.  Redo pullthrough for Hirschsprung disease.

Authors:  Matthew W Ralls; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2016-12-31       Impact factor: 1.827

Review 3.  Familial Hirschsprung's disease: a systematic review.

Authors:  Danielle Mc Laughlin; Prem Puri
Journal:  Pediatr Surg Int       Date:  2015-07-16       Impact factor: 1.827

4.  Management of Recurrent Post Redo Pull-Through Stricture - What is the Option?

Authors:  Sanjay Khope; Subash J Dalal
Journal:  Indian J Surg       Date:  2012-05-12       Impact factor: 0.656

Review 5.  Residual aganglionosis after pull-through operation for Hirschsprung's disease: a systematic review and meta-analysis.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-10       Impact factor: 1.827

6.  Re-operation for Hirschsprung's disease: experience in 24 patients from China.

Authors:  Qingfeng Sheng; Zhibao Lv; Xianmin Xiao
Journal:  Pediatr Surg Int       Date:  2012-02-23       Impact factor: 1.827

Review 7.  Hirschsprung-associated enterocolitis: prevention and therapy.

Authors:  Philip K Frykman; Scott S Short
Journal:  Semin Pediatr Surg       Date:  2012-11       Impact factor: 2.754

8.  Redo-endorectal pull through following various pull through procedures in Hirschsprung's disease.

Authors:  Florian Obermayr; Hans-Walter Hacker; Antje Bornemann; Martin Stern; Jörg Fuchs
Journal:  Langenbecks Arch Surg       Date:  2008-01-03       Impact factor: 3.445

9.  Laparoscopic vs. Transabdominal Treatment for Overflow Fecal Incontinence Due to Residual Aganglionosis or Transition Zone Pathology in Hirschsprung's Disease Reoperation.

Authors:  Feng Chen; Xiaoyu Wei; Xiaohua Chen; Lei Xiang; Jiexiong Feng
Journal:  Front Pediatr       Date:  2021-04-27       Impact factor: 3.418

10.  Acute Urinary Retention in a 47-month-old Girl Caused by the Giant Fecaloma.

Authors:  Ji Sook Park; Tae-Jin Park; Jung Seok Hwa; Ji-Hyun Seo; Chan-Hoo Park; Hee-Shang Youn
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.